Prolysis to present at a Gordon Research Conference in Lucca, Italy
5th February 2008

Prolysis is to present two programme posters at the New Antibacterial Discovery & Development, Gordon Research Conference, to be held in Lucca, Italy, on the 9th to 14th March 2008.
View full story

Prolysis receives a £3.48 million Seeding Drug Discovery award from the Wellcome Trust
15th January 2007

Prolysis has received one of three inaugural Seeding Drug Discovery awards from the Wellcome Trust. Prolysis will use these funds to progress its CDI-936 series of compounds towards a novel therapy for the treatment of staphylococcal infections.
View full story

Prolysis publishes a research paper describing a novel antibacterial target
12th January 2007

The paper is entitled: Essential bacterial functions encoded by gene pairs. J. Bacteriology, 189, 591-602.
View full story

Prolysis invited to present at Superbugs & Superdrugs conference in London
24th April 2006

Prolysis' Director of Research, Dr Lloyd Czaplewski will present at Superbugs & Superdrugs conference in London.
View full story

Professor Jeff Errington FRS completes the relocation of his research team
18th April 2006

Professor Jeff Errington FRS takes up his position as the Director of the Institute for Cell and Molecular Biosciences at the University of Newcastle upon Tyne.
View full story